Lyell Immunopharma
LYEL
LYEL
93 hedge funds and large institutions have $823M invested in Lyell Immunopharma in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 4 closing their positions.
Holders
93
Holders Change
+18
Holders Change %
+24%
% of All Funds
1.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
22
Increased
35
Reduced
16
Closed
4
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$3.86M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$39.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$90.9M |
3 |
3
BlackRock
New York
|
$86M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$21.6M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$14.9M |